This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3g0u

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (15:34, 1 November 2023) (edit) (undo)
 
(7 intermediate revisions not shown.)
Line 1: Line 1:
-
{{Seed}}
 
-
[[Image:3g0u.jpg|left|200px]]
 
-
<!--
+
==Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4==
-
The line below this paragraph, containing "STRUCTURE_3g0u", creates the "Structure Box" on the page.
+
<StructureSection load='3g0u' size='340' side='right'caption='[[3g0u]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
-
You may change the PDB parameter (which sets the PDB file loaded into the applet)
+
== Structural highlights ==
-
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
+
<table><tr><td colspan='2'>[[3g0u]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3G0U OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3G0U FirstGlance]. <br>
-
or leave the SCENE parameter empty for the default display.
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2&#8491;</td></tr>
-
-->
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=MDY:(2Z)-N-(3-CHLORO-2-METHOXYBIPHENYL-4-YL)-2-CYANO-3-HYDROXYBUT-2-ENAMIDE'>MDY</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene></td></tr>
-
{{STRUCTURE_3g0u| PDB=3g0u | SCENE= }}
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3g0u FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3g0u OCA], [https://pdbe.org/3g0u PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3g0u RCSB], [https://www.ebi.ac.uk/pdbsum/3g0u PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3g0u ProSAT]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[https://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[https://omim.org/entry/263750 263750]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.<ref>PMID:19915526</ref>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
 +
== Evolutionary Conservation ==
 +
[[Image:Consurf_key_small.gif|200px|right]]
 +
Check<jmol>
 +
<jmolCheckbox>
 +
<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/g0/3g0u_consurf.spt"</scriptWhenChecked>
 +
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
 +
<text>to colour the structure by Evolutionary Conservation</text>
 +
</jmolCheckbox>
 +
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3g0u ConSurf].
 +
<div style="clear:both"></div>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Pyrimidine biosynthesis is an attractive drug target in a variety of organisms, including humans and the malaria parasite Plasmodium falciparum. Dihydroorotate dehydrogenase, an enzyme catalyzing the only redox reaction of the pyrimidine biosynthesis pathway, is a well-characterized target for chemotherapeutical intervention. In this study, we have applied SPROUT-LeadOpt, a software package for structure-based drug discovery and lead optimization, to improve the binding of the active metabolite of the anti-inflammatory drug leflunomide to the target cavities of the P. falciparum and human dihydroorotate dehydrogenases. Following synthesis of a library of compounds based upon the SPROUT-optimized molecular scaffolds, a series of inhibitors generally showing good inhibitory activity was obtained, in keeping with the SPROUT-LeadOpt predictions. Furthermore, cocrystal structures of five of these SPROUT-designed inhibitors bound in the ubiquinone binding cavity of the human dihydroorotate dehydrogenase are also analyzed.
-
===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4===
+
Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases.,Davies M, Heikkila T, McConkey GA, Fishwick CW, Parsons MR, Johnson AP J Med Chem. 2009 May 14;52(9):2683-93. PMID:19351152<ref>PMID:19351152</ref>
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 3g0u" style="background-color:#fffaf0;"></div>
-
<!--
+
==See Also==
-
The line below this paragraph, {{ABSTRACT_PUBMED_19351152}}, adds the Publication Abstract to the page
+
*[[Dihydroorotate dehydrogenase 3D structures|Dihydroorotate dehydrogenase 3D structures]]
-
(as it appears on PubMed at http://www.pubmed.gov), where 19351152 is the PubMed ID number.
+
== References ==
-
-->
+
<references/>
-
{{ABSTRACT_PUBMED_19351152}}
+
__TOC__
-
 
+
</StructureSection>
-
==About this Structure==
+
-
3G0U is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3G0U OCA].
+
-
 
+
-
==Reference==
+
-
<ref group="xtra">PMID:19351152</ref><references group="xtra"/>
+
-
[[Category: Dihydroorotate oxidase]]
+
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
-
[[Category: Davis, M.]]
+
[[Category: Large Structures]]
-
[[Category: Fishwick, C W.G.]]
+
[[Category: Davis M]]
-
[[Category: Heikkila, T.]]
+
[[Category: Fishwick CWG]]
-
[[Category: Johnson, A P.]]
+
[[Category: Heikkila T]]
-
[[Category: McConkey, G A.]]
+
[[Category: Johnson AP]]
-
[[Category: Parsons, M R.]]
+
[[Category: McConkey GA]]
-
[[Category: Beta-alpha-barrel]]
+
[[Category: Parsons MR]]
-
[[Category: Fad]]
+
-
[[Category: Flavoprotein]]
+
-
[[Category: Membrane]]
+
-
[[Category: Mitochondrion]]
+
-
[[Category: Mitochondrion inner membrane]]
+
-
[[Category: Oxidoreductase]]
+
-
[[Category: Polymorphism]]
+
-
[[Category: Pyrimidine biosynthesis]]
+
-
[[Category: Tim-barrel]]
+
-
[[Category: Transit peptide]]
+
-
 
+
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 10 18:03:23 2009''
+

Current revision

Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4

PDB ID 3g0u

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3g0u"
Personal tools